These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35212542)

  • 21. A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells.
    Preston A; Frydenberg M; Haynes JM
    Br J Pharmacol; 2004 Jan; 141(2):302-10. PubMed ID: 14751869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blocking Adenosine/A2AR Pathway for Cancer Therapy].
    Liu J; Shi Y; Liu X; Zhang D; Bai Y; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):460-467. PubMed ID: 35899442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine-A2A Receptor Pathway in Cancer Immunotherapy.
    Sun C; Wang B; Hao S
    Front Immunol; 2022; 13():837230. PubMed ID: 35386701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Novel and Selective Adenosine A
    Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
    J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
    Ramanathan M; Pinhal-Enfield G; Hao I; Leibovich SJ
    Mol Biol Cell; 2007 Jan; 18(1):14-23. PubMed ID: 17065555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
    Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
    Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A
    Duroux R; Renault N; Cuelho JE; Agouridas L; Blum D; Lopes LV; Melnyk P; Yous S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):850-864. PubMed ID: 28661196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A
    Weng Y; Yang X; Zhang Q; Chen Y; Xu Y; Zhu C; Xie Q; Wang Y; Yang H; Liu M; Lu W; Song G
    Sci China Life Sci; 2024 May; 67(5):986-995. PubMed ID: 38319473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor.
    Eini H; Frishman V; Yulzari R; Kachko L; Lewis EC; Chaimovitz C; Douvdevani A
    Biochem Pharmacol; 2015 Nov; 98(1):110-8. PubMed ID: 26296573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist.
    Bai Y; Zhang X; Zheng J; Liu Z; Yang Z; Zhang X
    J Exp Clin Cancer Res; 2022 Oct; 41(1):302. PubMed ID: 36229853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Murray TF
    Am J Vet Res; 2007 Jun; 68(6):649-56. PubMed ID: 17542699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
    Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
    Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion.
    Chin A; Svejda B; Gustafsson BI; Granlund AB; Sandvik AK; Timberlake A; Sumpio B; Pfragner R; Modlin IM; Kidd M
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G397-405. PubMed ID: 22038827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
    J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
    Hide I; Padgett WL; Jacobson KA; Daly JW
    Mol Pharmacol; 1992 Feb; 41(2):352-9. PubMed ID: 1311411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.